Trade VYNE Therapeutics Inc. - VYNE CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.05 |
| Open | 2.03 |
| 1-Year Change | -44.38% |
| Day's Range | 1.94 - 2.06 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 2.08 | 0.15 | 7.77% | 1.93 | 2.08 | 1.93 |
| Jul 24, 2024 | 1.96 | -0.02 | -1.01% | 1.98 | 2.01 | 1.91 |
| Jul 23, 2024 | 2.03 | 0.02 | 1.00% | 2.01 | 2.04 | 1.98 |
| Jul 22, 2024 | 2.04 | 0.06 | 3.03% | 1.98 | 2.06 | 1.94 |
| Jul 19, 2024 | 2.07 | -0.02 | -0.96% | 2.09 | 2.12 | 1.99 |
| Jul 18, 2024 | 2.11 | -0.03 | -1.40% | 2.14 | 2.22 | 2.07 |
| Jul 17, 2024 | 2.19 | 0.05 | 2.34% | 2.14 | 2.20 | 2.12 |
| Jul 16, 2024 | 2.17 | -0.03 | -1.36% | 2.20 | 2.28 | 2.17 |
| Jul 15, 2024 | 2.19 | 0.11 | 5.29% | 2.08 | 2.26 | 2.06 |
| Jul 12, 2024 | 2.08 | 0.07 | 3.48% | 2.01 | 2.11 | 2.01 |
| Jul 11, 2024 | 2.04 | 0.18 | 9.68% | 1.86 | 2.05 | 1.86 |
| Jul 10, 2024 | 1.90 | 0.09 | 4.97% | 1.81 | 1.97 | 1.81 |
| Jul 9, 2024 | 1.88 | 0.00 | 0.00% | 1.88 | 1.92 | 1.85 |
| Jul 8, 2024 | 1.89 | 0.05 | 2.72% | 1.84 | 1.89 | 1.82 |
| Jul 5, 2024 | 1.78 | 0.05 | 2.89% | 1.73 | 1.78 | 1.73 |
| Jul 3, 2024 | 1.78 | 0.04 | 2.30% | 1.74 | 1.81 | 1.73 |
| Jul 2, 2024 | 1.78 | -0.04 | -2.20% | 1.82 | 1.86 | 1.75 |
| Jul 1, 2024 | 1.89 | 0.00 | 0.00% | 1.89 | 1.91 | 1.84 |
| Jun 28, 2024 | 1.93 | 0.10 | 5.46% | 1.83 | 1.93 | 1.75 |
| Jun 27, 2024 | 1.90 | 0.32 | 20.25% | 1.58 | 1.90 | 1.54 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
VYNE Therapeutics Inc. Company profile
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.| Industry: | Pharmaceuticals (NEC) |
685 Route 202/206, Suite 301A
BRIDGEWATER
NEW JERSEY 08807
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com